Usability of a Medication Event Reminder Monitor System (MERM) by Providers and Patients to Improve Adherence in the Management of Tuberculosis

Xiaoqiu Liu, Terrence Blaschke, Bruce Thomas, Sabina De Geest, Shiwen Jiang, Yongxin Gao, Xinxu Li, Elizabeth Whalley Buono, Stacy Buchanan, Zhiying Zhang and Shitong Huan
Additional contact information
Xiaoqiu Liu: National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
Terrence Blaschke: Department of Medicine, Stanford University, Stanford, CA 94305, USA
Bruce Thomas: The Arcady Group, Richmond, VA 23226, USA
Sabina De Geest: Institute of Nursing Science, University of Basel, CH-4056 Basel, Switzerland
Shiwen Jiang: National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
Yongxin Gao: National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
Xinxu Li: National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
Elizabeth Whalley Buono: The Arcady Group, Richmond, VA 23226, USA
Stacy Buchanan: The Arcady Group, Richmond, VA 23226, USA
Zhiying Zhang: PATH China Program, Beijing 100600, China
Shitong Huan: Bill and Melinda Gates Foundation, Beijing 100027, China

IJERPH, 2017, vol. 14, issue 10, 1-11

Abstract: Poor initiation and implementation and premature discontinuation of anti-tuberculous therapy, all forms of nonadherence, are major reasons for treatment failure, the development of drug-resistant tuberculosis, and transmission to other non-infected individuals. Directly Observed Therapy (DOT) has been the worldwide standard, but implementation of DOT is burdensome for providers and patients, especially in resource-limited settings, where most of the burden of active TB is located. Among the alternatives to DOT is electronic monitoring (EM) of drug dosing histories. Here we report a usability study of a newly-designed, modular electronic monitor product, called the MERM (Medication Event and Reminder Monitor), that is compatible with TB medication formats and supply chains in resource-limited settings. This study, done in a rural setting in China, showed that the use of the MERM for EM of TB medications was associated with a high degree of user performance, acceptability, and satisfaction among both TB patients and medical staff. Based on these data, EM is becoming the standard of care for drug-susceptible TB patients in China and scaled implementations in several other countries with high TB burden have begun. In addition, the MERM is being used in MDR-TB patients and in clinical trials involving patients with TB/HIV and latent TB.

Keywords: adherence; tuberculosis; management; monitoring technology; usability (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2017
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/14/10/1115/pdf (application/pdf)
https://www.mdpi.com/1660-4601/14/10/1115/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:14:y:2017:i:10:p:1115-:d:113104

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().